However, as the disease progresses, macrophages in dystrophic muscle shift to a CD163+/CD206+ phenotype that increases muscle fibrosis23 and is characteristic of type 2 immunity; much of the lethality of DMD is attributable to fibrosis of cardiac and respiratory muscles. This evidence concerns the gene CD163 and Duchenne muscular dystrophy.